D. E. Shaw & Co., Inc. - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 55 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$272,825
-54.3%
216,528
-73.7%
0.00%
-100.0%
Q1 2023$596,855
-23.4%
823,362
-44.1%
0.00%0.0%
Q4 2022$779,075
-47.1%
1,474,125
-16.6%
0.00%
-50.0%
Q3 2022$1,473,000
-40.7%
1,767,337
-22.5%
0.00%
-33.3%
Q2 2022$2,485,000
-48.5%
2,279,636
-41.0%
0.00%
-40.0%
Q1 2022$4,829,000
-27.2%
3,863,135
-6.9%
0.01%
-16.7%
Q4 2021$6,637,000
+127.2%
4,147,809
+362.9%
0.01%
+100.0%
Q3 2021$2,921,000896,0570.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
QCM Cayman, Ltd. 22,301$36,0000.22%
XTX Topco Ltd 17,275$28,0000.02%
TWO SIGMA INVESTMENTS, LP 2,371,193$3,794,0000.01%
TWO SIGMA ADVISERS, LP 1,597,930$2,557,0000.01%
D. E. Shaw & Co., Inc. 4,147,809$6,637,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 129,916$208,0000.01%
Graham Capital Management, L.P. 73,105$116,0000.01%
Caption Management, LLC 300,000$480,0000.01%
Engineers Gate Manager LP 60,809$97,0000.00%
Castleview Partners, LLC 800$500,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders